Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Aripiprazole for clozapine associated medical morbidity

Trial Profile

Aripiprazole for clozapine associated medical morbidity

Phase of Trial: Phase IV

Latest Information Update: 12 Sep 2012

At a glance

  • Drugs Aripiprazole (Primary) ; Clozapine
  • Indications Schizoaffective disorder; Schizophrenia
  • Focus Adverse reactions
  • Most Recent Events

    • 04 Sep 2012 Results published in the Acta Psychiatrica Scandinavica.
    • 01 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Jul 2008 The expected completion date for this trial is now 1 Oct 2009, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top